Related Experiment Video
Updated: Jun 27, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate
Deepak Kadiyala1, David A Roer, Mark A Perazella
1St Mary's Hospital, Waterbury, CT, USA.
Abstract:
Nephrogenic systemic fibrosis (NSF) is a debilitating fibrosing disorder of patients with kidney disease that is associated with gadolinium-based contrast exposure. Most cases are linked to gadodiamide. Gadoversetamide, an agent with chelate characteristics similar to gadodiamide, has rarely been described to cause NSF. With the exception of normalization of kidney function, there are no consistently effective therapies for patients with NSF. We describe 3 cases of NSF in patients with end-stage renal disease after gadolinium-based contrast exposure. Two patients received gadoversetamide and the third received gadodiamide. All 3 patients were treated early in their disease course with intravenous sodium thiosulfate and responded with improved skin changes and joint mobility.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Renal Drug Excretion: Tubular Secretion
Antihypertensive Drugs: Thiazide-Class Diuretics
